American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Netflix
NFLX
|
+$348M |
| 2 |
Booking.com
BKNG
|
+$293M |
| 3 |
TSMC
TSM
|
+$239M |
| 4 |
Howmet Aerospace
HWM
|
+$231M |
| 5 |
Royal Caribbean
RCL
|
+$212M |
Top Sells
| 1 |
Apple
AAPL
|
+$570M |
| 2 |
Palantir
PLTR
|
+$375M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$235M |
| 4 |
Progressive
PGR
|
+$222M |
| 5 |
Salesforce
CRM
|
+$205M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Financials | 14.55% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 10.04% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRD
2676
DELISTED
Third Harmonic Bio
THRD
| $186K | ﹤0.01% |
34,299
+2,632
| +8% | +$14.3K |
|
2677
Vimeo
VMEO
$1.28B
| $183K | ﹤0.01% |
45,238
-43,482
| -49% | -$176K |
|
|
VIGL
2678
DELISTED
Vigil Neuroscience
VIGL
| $182K | ﹤0.01% |
22,879
+2,621
| +13% | +$20.8K |
|
2679
Bausch Health
BHC
$2.68B
| $182K | ﹤0.01% |
27,236
| – | – |
|
2680
Absci
ABSI
$381M
| $181K | ﹤0.01% |
70,562
-94,616
| -57% | -$243K |
|
2681
4D Molecular Therapeutics
FDMT
$318M
| $181K | ﹤0.01% |
48,810
+5,026
| +11% | +$18.6K |
|
2682
Blue Foundry Bancorp
BLFY
$198M
| $181K | ﹤0.01% |
18,913
-542
| -3% | -$5.19K |
|
2683
MeridianLink
MLNK
$1.47B
| $179K | ﹤0.01% |
11,055
-28,260
| -72% | -$459K |
|
2684
Day One Biopharmaceuticals
DAWN
$729M
| $178K | ﹤0.01% |
27,330
+12,915
| +90% | +$83.9K |
|
2685
Duluth Holdings
DLTH
$133M
| $172K | ﹤0.01% |
81,973
| – | – |
|
2686
Innovative Solutions & Support
ISSC
$197M
| $172K | ﹤0.01% |
12,386
+2,228
| +22% | +$30.9K |
|
2687
Arvinas
ARVN
$568M
| $169K | ﹤0.01% |
+22,964
| New | +$169K |
|
2688
CuriosityStream
CURI
$281M
| $167K | ﹤0.01% |
+29,663
| New | +$167K |
|
2689
Nkarta
NKTX
$140M
| $163K | ﹤0.01% |
98,097
+1,259
| +1% | +$2.09K |
|
2690
HF Foods Group
HFFG
$177M
| $162K | ﹤0.01% |
+50,955
| New | +$162K |
|
2691
Cerence
CRNC
$450M
| $162K | ﹤0.01% |
+15,851
| New | +$162K |
|
2692
Seer Inc
SEER
$115M
| $161K | ﹤0.01% |
75,169
-832
| -1% | -$1.78K |
|
2693
Asana
ASAN
$3.12B
| $158K | ﹤0.01% |
+11,732
| New | +$158K |
|
2694
Design Therapeutics
DSGN
$343M
| $156K | ﹤0.01% |
46,385
+1,970
| +4% | +$6.64K |
|
2695
Lantronix
LTRX
$174M
| $156K | ﹤0.01% |
54,223
-95
| -0.2% | -$273 |
|
2696
SITE Centers
SITC
$463M
| $152K | ﹤0.01% |
13,424
-440
| -3% | -$4.98K |
|
|
PLL
2697
DELISTED
Piedmont Lithium
PLL
| $150K | ﹤0.01% |
25,753
+1,958
| +8% | +$11.4K |
|
2698
CS Disco
LAW
$357M
| $150K | ﹤0.01% |
34,215
-1,342
| -4% | -$5.87K |
|
2699
Star Group
SGU
$387M
| $149K | ﹤0.01% |
12,697
-198
| -2% | -$2.32K |
|
2700
BioCryst Pharmaceuticals
BCRX
$1.66B
| $146K | ﹤0.01% |
16,331
-121,382
| -88% | -$1.09M |
|